Intervention with costimulatory pathways as a therapeutic approach for graft-versus-host disease.
Graft-versus-host disease (GVHD) is mediated by mature donor T cells contained in the hematopoietic stem cell graft. During the development of GVHD, signaling through a variety of costimulatory receptors plays an important role in allogeneic T cell responses. Even though delivery of costimulatory signals is a prerequisite for full activation of donor T cells in the phase of their interactions with host APCs, their involvement with GVHD might occur over multiple stages. Like many other aspects of GVHD, promise of therapeutic interventions with costimulatory pathways has been gleaned from preclinical models. In this review, I summarize some of the advances in roles of costimulatory molecules in GVHD pathophysiology and discuss preclinical approaches that warrant further exploration in the clinic, focusing on novel strategies to delete pathogenic T cells.
Kwon
Byungsuk
B
School of Biological Sciences, University of Ulsan, Ulsan 680-749, Korea. bkwon@ulsan.ac.kr
D000818:Animals; D006086:Graft vs Host Disease / Q000276:immunology* / Q000378:metabolism / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D014181:Transplantation Immunology / Q000276:immunology; D014184:Transplantation, Homologous
J Exp Med. 2005 Aug 1;202(3):445-55
16061730
J Exp Med. 2006 Apr 17;203(4):883-95
16606670
Blood. 2005 Mar 1;105(5):2206-13
15522958
Nat Med. 2002 Dec;8(12):1405-13
12426559
Nat Rev Drug Discov. 2010 Apr;9(4):325-38
20305665
J Exp Med. 2005 Jun 20;201(12):1925-35
15967822
Nat Rev Immunol. 2007 May;7(5):340-52
17438575
Blood. 2007 Jul 15;110(2):776-82
17363737
Blood. 2005 Apr 15;105(8):3372-80
15618467
J Clin Invest. 2007 Oct;117(10):3029-41
17853940
J Immunol. 1995 Aug 15;155(4):1757-66
7636232
J Immunol. 1996 Nov 1;157(9):4258-67
8892665
Blood. 1998 Oct 15;92(8):2963-70
9763584
J Immunol. 2006 Jun 15;176(12):7394-401
16751384
Nat Med. 2004 Oct;10(10):1088-94
15448685
N Engl J Med. 2006 Sep 7;355(10):1018-28
16908486
Am J Transplant. 2007 Dec;7(12):2683-92
17924994
Blood. 2002 Jun 15;99(12):4601-9
12036894
J Immunol. 2010 May 1;184(9):4770-8
20351189
J Immunol. 2006 May 1;176(9):5223-31
16621987
J Exp Med. 1999 Nov 15;190(10):1535-40
10562327
J Immunol. 1990 Jan 1;144(1):16-22
2153162
Nat Rev Immunol. 2009 Apr;9(4):271-85
19319144
J Clin Invest. 2002 Feb;109(4):549-57
11854328
Biol Blood Marrow Transplant. 2009 Mar;15(3):306-14
19203721
Trends Immunol. 2010 Jun;31(6):236-45
20362509
Blood. 1994 Jun 15;83(12):3815-25
7515723
Nat Med. 1999 Nov;5(11):1298-302
10545997
Immune Netw. 2009 Jun;9(3):84-9
20107537
J Clin Invest. 2003 May;111(10):1505-18
12750400
J Immunol. 2005 Oct 15;175(8):4897-903
16210591
J Immunol. 1997 Jan 1;158(1):29-39
8977172
Blood. 2010 Mar 11;115(10):1941-8
20068221
Immunol Rev. 2009 May;229(1):5-11
19426211
Immunology. 2004 Sep;113(1):89-98
15312139
J Immunol. 2009 Apr 1;182(7):4107-15
19299708
J Clin Invest. 2006 Apr;116(4):1025-36
16528411
Annu Rev Immunol. 2007;25:139-70
17129175
J Immunol. 1999 Apr 15;162(8):4373-6
10201970
Blood. 2005 Feb 1;105(3):1355-61
15459004
Immunol Rev. 2009 May;229(1):271-93
19426228
J Immunol. 2001 Nov 1;167(9):4981-6
11673505
Blood. 2005 Mar 1;105(5):2227-34
15522961
J Immunol. 2006 Jul 15;177(2):814-21
16818735
J Immunol. 2007 Oct 1;179(7):4307-12
17878324
J Immunol. 2001 Mar 1;166(5):3174-83
11207270
Blood. 2005 Nov 1;106(9):3285-92
15956289
J Immunol. 2002 Feb 1;168(3):1457-65
11801689
Blood. 2007 Jun 1;109(11):4882-9
17244673
Blood. 2007 Jan 1;109(1):365-73
16931626
J Immunol. 2008 Nov 15;181(10):7380-9
18981161
Nat Med. 1997 Jun;3(6):682-5
9176498
J Exp Med. 2004 Jul 19;200(2):149-57
15249593
Invest Ophthalmol Vis Sci. 2005 Feb;46(2):596-603
15671287
Clin Exp Allergy. 2006 Mar;36(3):377-85
16499650
J Immunol. 1998 May 1;160(9):4225-31
9574523
J Immunol. 2008 Jul 1;181(1):47-61
18566369
Transplantation. 2007 Mar 27;83(6):774-82
17414712
J Clin Invest. 2004 Jun;113(11):1624-30
15173889
Blood. 2003 May 1;101(9):3741-8
12521997
J Immunol. 2001 Nov 15;167(10):5741-8
11698447
J Clin Invest. 1994 Sep;94(3):1333-8
7521888
Nat Med. 2000 Jun;6(6):673-9
10835684
J Immunol. 2004 Aug 15;173(4):2428-34
15294956
Cancer Res. 2010 May 15;70(10):3945-54
20406989
Biol Blood Marrow Transplant. 2008 Apr;14(4):365-78
18342778
J Immunol. 2004 Sep 1;173(5):2933-41
15322151
J Immunol. 2003 Aug 1;171(3):1272-7
12874215
J Immunol. 2007 Dec 1;179(11):7295-304
18025172
J Clin Invest. 1998 Aug 1;102(3):473-82
9691083